UBS analyst Xian Deng maintained a Buy rating on Ipsen (0MH6 – Research Report) today and set a price target of €145.00. The company’s shares ...

Ipsen SA (IPSEF) reports robust financial performance with a 9.9% sales increase and strategic pipeline developments, despite ...

Ipsen expects total sales growth of more than 5% at constant exchange rates in 2025, supported by the continued expansion of products like IQIRVO, ONIVYDE, and Bylvay. However, Somatuline faces ...